Debt |
9 Months Ended |
|---|---|
Jul. 31, 2026 | |
| Debt Disclosure [Abstract] | |
| Debt [Text Block] |
8. Debt Loan Agreement with University of British Columbia ("UBC") In connection with the purchase of the patent, on November 20, 2023, the Company entered into a loan agreement with UBC. The loan was for $136,539 CAD, bearing interest at 15%, and had a maturity date of November 20, 2026. There are no required payments under the loan, as the full amount was due upon maturity. As of October 31, 2024, the outstanding principal was $98,117 ($136,539 CAD). On March 4, 2025, the Company paid UBC a total of $148,037 ($213,795 CAD) in settlement of the PAA. The settlement included interest of $27,256 CAD and an accounts payable of $50,000 CAD. Interest expense was $0 and $43 during the three months ended July 31, 2026, and 2025, respectively. For the nine months ended July 31, 2026, and 2025, interest expense totaled $0 and $4,949, respectively. Insurance Funding Agreement On May 5, 2026, the Company obtained an insurance policy with total premiums equaling $625,535 on which a cash down payment of $155,750 was paid. On May 12, 2026, the Company entered into an agreement with a third party to finance the remaining premiums of $469,785. The financing agreement had nine equal monthly payments of $53,943 each month, accrued interest at a rate of 7.95% and a maturity date of February 5, 2027. Total financing charges equal $15,699. As of July 31, 2026, the outstanding balance, including principal and interest, was $377,598 and was reported on the unaudited condensed interim balance sheet as insurance funding agreement. |